Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 1,844 | 2,262 | 3,487 | 3,213 | 3,710 |
| Operating Income | -1,844 | -2,262 | -3,487 | -3,213 | -3,710 |
| Other Income | 102 | 205 | 164 | 250 | 227 |
| Pre-tax Income | -1,742 | -2,057 | -3,323 | -2,963 | -3,483 |
| Net Income Continuous | -1,742 | -2,057 | -3,323 | -2,963 | -3,483 |
| Net Income | $-1,742 | $-2,057 | $-3,323 | $-2,963 | $-3,483 |
| EPS Basic Total Ops | -0.08 | -0.32 | -0.56 | -0.76 | -0.20 |
| EPS Basic Continuous Ops | -0.07 | -0.36 | -0.58 | -0.80 | -0.20 |
| EPS Diluted Total Ops | -0.08 | -0.32 | -0.56 | -0.76 | -0.20 |
| EPS Diluted Continuous Ops | -0.07 | -0.36 | -0.58 | -0.80 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -1.40 | -0.36 | -0.56 | -0.64 | -0.80 |
| EBITDA(a) | $-1,844 | $-2,262 | $-3,487 | $-3,213 | $-3,710 |